1. Home
  2. BDL vs PMVP Comparison

BDL vs PMVP Comparison

Compare BDL & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

N/A

Current Price

$46.29

Market Cap

84.6M

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

N/A

Current Price

$1.53

Market Cap

86.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BDL
PMVP
Founded
1959
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.6M
86.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
BDL
PMVP
Price
$46.29
$1.53
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $4.20
AVG Volume (30 Days)
21.4K
★ 660.6K
Earning Date
08-12-2026
11-11-2026
Dividend Yield
★ 1.29%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.09
N/A
Revenue
★ $205,248,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.01
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.55
$1.02
52 Week High
$52.12
$1.91

Technical Indicators

Market Signals
Indicator
BDL
PMVP
Relative Strength Index (RSI) 54.14 54.48
Support Level $29.36 $1.05
Resistance Level $47.99 $1.90
Average True Range (ATR) 1.91 0.14
MACD 0.16 -0.01
Stochastic Oscillator 73.78 43.65

Price Performance

Historical Comparison
BDL
PMVP

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: